Dr. Amandeep Salrotra explains Tregzi, FDA-Approved Therapy
Jul 30, 202612m
Dr. Salrotra explains how Tregzi works for patients who are undergoing a stem cell transplant or a bone marrow transplant.
Loading…
Loading…
Hosted by Unknown Host · 🇺🇸 US · EN · 61 episodes
Established thought leaders with verified media credentials.
"Podcasts for Patients" from the Aplastic Anemia and MDS International Foundation features interviews with Bone Marrow Failure Specialists and PatientsFor more, see our podcast page at: https://www.aamds.org/podcast/
Unknown Host hosts AAMDSIF Podcasts for Patients, a health show with 61 episodes published.
Dr. Salrotra explains how Tregzi works for patients who are undergoing a stem cell transplant or a bone marrow transplant.
Listen to Barry describe the diagnosis, watch-and-wait, treatment, and survivorship for MDS, or Myelodysplastic Syndromes
Learn from Dr. Richard Childs, RADM, as he explains the FDA approval of Omnisirge for treating patients with Severe Aplastic Anemia, or SAA.
Claire was a NICU nurse, so she had never experienced a pattient with Aplastic Anemia. Then, she became a patient herself. Find out how she learned she was stronger than she knew in this episode.
When Donna picked up a Hope Stone at her first AAMDSIF Patient and Family Conference, she couldn't foresee that she would be carrying it in her pocket on all challenging days. Listen here as Donna shares how she found ho
As an active, working, mom, Shaquilla was used to being busy, and enjoying all the activities that come with children. Then she started getting tired. She wasn't just tired; she couldn't keep up with the daily routine an
Pain. Blood Clots. Diagnosis. Listen to Shane describe his journey to diagnosis, then to ongoing, successful, treatment in this recent episode. He will inspire you to advocate for yourself, and to keep focused on your ne
Dr. Satheesh Chonat describes the use of this medication for pediatric patients with PNH, or paroxysmal nocturnal hemoglobinuria. For more podcast episodes like this, please visit aamds.org/podcast (https://www.aamds.org
Dr. Carlos De Castro describes the use of this medication for patients with PNH. Listen now. For more podcast episodes like this, please visit aamds.org/podcast-episodes (https://www.aamds.org/education/podcast-episodes)
This new therapy is designed for patients with Low-Risk MDS. Dr Shallis explains which patients may see help for their anemia with this treatment as well as manageable side effects. For more podcast episodes, subscribe o
Dr. Caroline Piatek describes the purpose and use of this new drug approval for some patients with PNH, or Paroxysmal Nocturnal Hemoglobinuria
Damian describes his story of diagnosis, treatment, and bone marrow transplant in this compelling episode.
Director for Patient Services, Leigh Clark, interviews Ron Duncan about his journey with Pure Red Cell Aphasia, or PRCA.
Dr. Roma Rajput explains the origins and treatment of hepatitis-associated Aplastic Anemia in this AAMDSIF Podcast for Patients Episode.
AAMDSIF Director of Patient Programs, Leigh Clark, asks Brian about his life before diagnosis, during "watch and wait," through transplant, to now. Listen here to his myelodysplastic syndromes, or MDS, patient journey.
AAMDSIF Director of Patient Services, Leigh Clark, asks Mario about his journey with Aplastic Anemia. The conversation includes treatment and survivorship.
Evan was biking 20 miles each day, when his dad noticed physical changes. The diagnosis: PNH, or paroxysmal nocturnal hemoglobinuria. Listen to Evan describe his journey with this rare disease in this episode of Podcast
Dr. Bart Scott explains how the approval for the oral medication, Fabhalta, or iptacopan, may be beneficial for particular patients with PNH
Discussion about recent FDA approval of Tibsovo with Dr. Amir Fathi, who is an associate professor of medicine at Harvard Medical School and the director of the leukemia program at Massachusetts General Hospital.
Dr. Guillermo Garcia Manero explains the new authorization for use of the drug, Reblozyl®.
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
AAMDSIF Podcasts for Patients has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.
AAMDSIF Podcasts for Patients is hosted by Unknown Host. The show is categorised under health (fitness) and has published 61 episodes.
AAMDSIF Podcasts for Patients has published 61 episodes.
AAMDSIF Podcasts for Patients regularly covers health, fitness. It sits in the health category, with a fitness focus.
AAMDSIF Podcasts for Patients is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
AAMDSIF Podcasts for Patients hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of AAMDSIF Podcasts for Patients average 14 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates AAMDSIF Podcasts for Patients's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 3 days ago.